Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2022

01-01-2022 | Colonoscopy | EDITORIAL

Does Fellow Participation Increase the Adenoma Detection Rate?

Authors: Emanuele Sinagra, Rita Alloro, Ilaria Tarantino

Published in: Digestive Diseases and Sciences | Issue 1/2022

Login to get access

Excerpt

The primary operator-dependent quality indicator for colonoscopy is the adenoma detection rate (ADR), defined as the proportion of screening colonoscopies detecting at least one adenoma, which ideally should be ≥ 25% overall (≥ 30 for male patients and ≥ 20% for female patients) [1]. In fact, the ADR is inversely related to both the risk of interval colorectal cancer (cancer diagnosed on a surveillance exam after an initial negative screening colonoscopy), as well as death caused by interval colorectal cancer [2, 3]. Several factors affect the ADR, including: (1) patient features such as age, gender, and family history; (2) procedural characteristics such as optimized colon cleansing, withdrawal time, and methods of sedation; (3) ancillary maneuvers such as positioning, right colon retroflexion, and the use of water-aided methods; (4) technologic advances such as new generation endoscopes, increased field of view, add-on tools, virtual chromoendoscopy, and artificial intelligence; and (5) endoscopist experience [4, 5]. …
Literature
2.
go back to reference Corley DA, Jensen CD, Marks AR et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 2014;370:1298–1306CrossRef Corley DA, Jensen CD, Marks AR et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 2014;370:1298–1306CrossRef
3.
go back to reference Kaminski MF, Regula J, Kraszewska E et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010;362:1795–1803CrossRef Kaminski MF, Regula J, Kraszewska E et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010;362:1795–1803CrossRef
7.
go back to reference Friedman M, Arora G, Green J. Fellow involvement during colonoscopy does not reduce adenoma detection rate. Dig Dis Sci 2011;56:919CrossRef Friedman M, Arora G, Green J. Fellow involvement during colonoscopy does not reduce adenoma detection rate. Dig Dis Sci 2011;56:919CrossRef
8.
go back to reference Kim YD, Bae WK, Choi YH et al. Difference in adenoma detection rates according to colonoscopic withdrawal times and the level of expertise. Korean J Gastroenterol 2014;64:278–283CrossRef Kim YD, Bae WK, Choi YH et al. Difference in adenoma detection rates according to colonoscopic withdrawal times and the level of expertise. Korean J Gastroenterol 2014;64:278–283CrossRef
Metadata
Title
Does Fellow Participation Increase the Adenoma Detection Rate?
Authors
Emanuele Sinagra
Rita Alloro
Ilaria Tarantino
Publication date
01-01-2022
Publisher
Springer US
Keyword
Colonoscopy
Published in
Digestive Diseases and Sciences / Issue 1/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-06889-4

Other articles of this Issue 1/2022

Digestive Diseases and Sciences 1/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.